Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection.
Int J Cancer. 2023 Feb 15;152(4):661-671. doi: 10.1002/ijc.34273. Epub 2022 Sep 28.
Int J Cancer. 2023.
PMID: 36056571
Free PMC article.
First-Generation Epidermal Growth Factor Receptor Inhibitors Plus Antiangiogenic Drugs Versus Third-Generation Epidermal Growth Factor Receptor Inhibitors in Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis.
Mosca M, Conci N, Di Federico A, Tateo V, Favorito V, Zappi A, Gelsomino F, De Giglio A.
Mosca M, et al. Among authors: favorito v.
JCO Precis Oncol. 2023 May;7:e2300073. doi: 10.1200/PO.23.00073.
JCO Precis Oncol. 2023.
PMID: 37262392
Review.
Item in Clipboard
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies.
Favorito V, Ricciotti I, De Giglio A, Fabbri L, Seminerio R, Di Federico A, Gariazzo E, Costabile S, Metro G.
Favorito V, et al.
Expert Opin Emerg Drugs. 2024 Apr 8:1-16. doi: 10.1080/14728214.2024.2331139. Online ahead of print.
Expert Opin Emerg Drugs. 2024.
PMID: 38572595
Review.
Item in Clipboard
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer.
Di Federico A, Ricciotti I, Favorito V, Michelina SV, Scaparone P, Metro G, De Giglio A, Pecci F, Lamberti G, Ambrogio C, Ricciuti B.
Di Federico A, et al. Among authors: favorito v.
Curr Oncol Rep. 2023 Sep;25(9):1017-1029. doi: 10.1007/s11912-023-01436-y. Epub 2023 Jun 28.
Curr Oncol Rep. 2023.
PMID: 37378881
Review.
Item in Clipboard
Cite
Cite